Work

The Results of a Phase I Study using Velcade (Bortezomib), Cladribine, and Rituximab (VCR) in treating Mantle Cell Lymphoma

Year: 2016

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.1792.1792

Authors: Jeffrey J. Pu, W. Christopher Ehmann, Jason Liao, Christine Capper, Michelle Levy, David F. Claxton, Witold B. Rybka, Raymond J. Hohl, Elliot M. Epner

Institution: Penn State Cancer Institute

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2594889630

FWCI: 0.303

Cites:

Cited by: 7

Related to: 10